Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Understanding the advantages and disadvantages of zero based budgeting can guide your financial choices. Make informed decisions for a better budget.
28,655 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
FedEx says it will return tariff refunds to customers who paid them after a Supreme Court ruling curbed IEEPA tariffs...
Fintech is reshaping how we invest and borrow, but rapid tech, crypto, and AI bring new risks. This guide distills ex...
As Walmart gears up for 2027, investors need a clear view of how groceries, online sales, and international markets s...
SMR stocks like NuScale Power and Oklo have dazzled investors, but 2026 could test whether execution, not hype, drive...
Prediction markets promise quick wins, but long-term wealth tends to come from owning durable businesses. This guide ...
Paysign's 2025 earnings paint a picture of a niche fintech player balancing steady card-services revenue with new par...
Investors are weighing the latest earnings from D-Wave Quantum. While losses persisted, revenue beat expectations in ...
A flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
A notable AI stock has fallen about 30% this year. This article lays out a practical, battle-tested framework to judg...
When the stock market's "fear gauge" ticks higher, it often precedes a meaningful move. This guide explains what that...
A steep 2026 selloff has investors weighing Microsoft through a new lens. This guide breaks down the case for microso...